Dr David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.
I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.
I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.
Treatment variation in early breast cancer in the UK.
Dodwell D. et al, (2020), BMJ, 371
Surgery of the primary tumour in women with metastatic breast cancer at diagnosis in England and Wales – how do treatment rates vary at an individual and regional level?
Miller K. et al, (2020), European Journal of Cancer, 138, S116 - S117
Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
Mannu GS. et al, (2020), BMJ, 369
Data Resource Profile: The Systemic Anti-Cancer Therapy (SACT) dataset.
Bright CJ. et al, (2020), Int J Epidemiol, 49, 15 - 15l
Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England
DODWELL D., (2020), Journal of Geriatric Oncology